MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Programming of deep brain stimulators in Parkinson’s disease with early motor complications (EARLYSTIM-study)

K. Knudsen, J.-L. Houeto, P. Krack, J. Rau, C. Schade-Brittinger, A. Schnitzler, W.M.M. Schuepbach, L. Timmermann, L. Tonder, G. Deuschl (Kiel, Germany)

Meeting: 2017 International Congress

Abstract Number: 1403

Keywords: Deep brain stimulation (DBS), Parkinsonism

Session Information

Date: Thursday, June 8, 2017

Session Title: Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: Recently the EARLYSTIM study showed the superior effect of subthalamic stimulation to best medical treatment in Parkinson`s disease with early motor complications. 

Background: EARLYSTIM patients were implanted and programmed in highly specialized DBS centers in Germany and France according to current and common guidelines for all the centers but customized for each patient. 

Methods: Statistical analysis of DBS-programming was performed in the cohort of 114 patients with bilateral programming at the 12 and 24 month visits. We investigated the influence of atypical programming (non-unipolar, frequency other than 130 Hz and impulse-width other than 60µs), change of contact and energy changes in the course of stimulation in relation to clinical outcome. The influence of baseline characteristics was also assessed.

Results: The mean stimulation energy (TEED, total electrical energy delivered) increased on both sides over time. The second highest contact was used mostly. Unipolar programming (using one single contact) was sufficient in more than 80% of leads. TEED was significantly higher on the initially affected side. There was no statistically significance between the patient group needing contact changes (n=32, 28.1%) or not regarding outcomes (UPDRS II worst-mobility and total, PDQ-39 mobility and ADL subscores). Additionally, we did not find a significant influence of typical (n=83; 72.8%) versus non-typical programming. Interestingly there was no significant difference in TEED for the first implanted versus second implanted side. We found higher TEED in the patient group with less improvement of the PDQ-39 (≤20%).

Conclusions: Monopolar stimulation using one single contact was found sufficient for optimal treatment for the majority of EARLYSTIM patients. The more affected side and patients with lower improvement of life quality were associated with higher stimulation energy. Although the study was not designed to compare different stimulation regimens, these results emphasize that experienced programming can provide homogeneous results.  

To cite this abstract in AMA style:

K. Knudsen, J.-L. Houeto, P. Krack, J. Rau, C. Schade-Brittinger, A. Schnitzler, W.M.M. Schuepbach, L. Timmermann, L. Tonder, G. Deuschl. Programming of deep brain stimulators in Parkinson’s disease with early motor complications (EARLYSTIM-study) [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/programming-of-deep-brain-stimulators-in-parkinsons-disease-with-early-motor-complications-earlystim-study/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/programming-of-deep-brain-stimulators-in-parkinsons-disease-with-early-motor-complications-earlystim-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley